INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![2020 Onsite What We Do Josh Anderson]( "What Sponsors Must Know To Safeguard Ocular Endpoints")
What Sponsors Must Know To Safeguard Ocular EndpointsExplore the necessity of incorporating imaging methodologies early in the trial design to improve data quality and overall trial efficiency.
-
![Japan Globe]( "Building A Gold Standard Trial Experience In Japan")
Building A Gold Standard Trial Experience In JapanHear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.
-
![Elevating the site voice]( "Elevating The Site Voice")
Elevating The Site VoiceA decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.
-
![Scientists Working On Computer GettyImages-1090255692]( "Building One Home for Sites")
Building One Home for SitesWatch this presentation and demonstration of One Home for Sites for the latest updates on how the industry is coming together — even competitors — to alleviate the technology burden on research sites.
-
Breaking Free From Process Paralysis In Clinical Trials1/13/2025
Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.
-
Adaptive Clinical Trials8/20/2024
An adaptive study design can be especially useful if there are uncertainties specific to your drug. Adjusting your study as data accumulates means getting answers sooner.
-
Complex Trials, Clear Budgets: Global Clinical Trial Budgeting Strategies11/4/2024
Gain valuable insights into efficient budgeting strategies and discover how technology can offer a holistic solution for managing investigator grant costs.
-
Phase 1 Trial In Painful Diabetic Peripheral Neuropathy2/24/2026
A complex Phase 1 neuropathy study with overnight stays achieved full enrollment and retention through careful planning, strong participant engagement, and disciplined operational execution.
-
How Australia's Leading CRO Is Driving Biotech's Acceleration From First-In-Human To Global Markets4/8/2026
The next era of clinical trials will be defined by global expansion across the Asia-Pacific region, rapid and cost-effective pathways to regulatory approval, and reliable, patient-centric leadership.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![teamwork collaboration data analysis-GettyImages-1473508651]( "Accelerating Biologics Through Development Milestones")
Whether you're aiming to run a pivotal trial or multiple studies, discover how Veristat's full-service support can drive your biologic therapies from inception to market success.
-
![iOver the Shoulder Shot of Senior Medical Scientist Working Stock-1050311748]( "Multitherapeutic Limitations: Knowing How To Choose The Right Resource")
Chief medical officers looking for outsourcing services on a study are often fed lines from large CROs on how they can provide individuals with multitherapeutic backgrounds.
-
![GettyImages-1331910730 payment]( "Why IQVIA Participant Payments?")
Learn about how this participant-friendly technology ensures efficient and secure payments, enhancing the clinical trial experience for all involved.
-
![GettyImages-2189405678-GLP-1-obesity]( "Precision Partnership For Obesity Clinical Trials")
Accelerate obesity research with specialized expertise in GLP-1 trials. Our approach ensures rapid enrollment, high participant retention, and clean data through a patient-centered model.
-
![GettyImages-887882750 global consulting]( "Portfolio Optimization Strategic Consulting")
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.
In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.
